Induction therapy with oral tacrolimus provides long-term benefit in thiopurine-naïve refractory ulcerative colitis patients despite low serum albumin levels
Preprint in Research Square (December 2023)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Analysis of the short-term efficacy of tacrolimus in the treatment of refractory Crohn′s disease
Article in Chinese Journal of Inflammatory Bowel Diseases (April 2022)
Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome
Article in World Journal of Gastroenterology (June 2021)